NCT00288951View on ClinicalTrials.gov

Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

690

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 0.004% with and without BAK

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY